Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthritis, Experimental | 14 | 2013 | 52 | 2.210 |
Why?
|
| Proteoglycans | 15 | 2013 | 117 | 1.330 |
Why?
|
| Th1 Cells | 4 | 2013 | 23 | 0.900 |
Why?
|
| Arthritis, Rheumatoid | 11 | 2015 | 251 | 0.890 |
Why?
|
| Mice | 27 | 2017 | 1249 | 0.740 |
Why?
|
| Interleukin-4 | 5 | 2008 | 17 | 0.710 |
Why?
|
| Interleukin-17 | 4 | 2013 | 12 | 0.710 |
Why?
|
| Interferon-gamma | 7 | 2013 | 72 | 0.630 |
Why?
|
| Mice, Inbred BALB C | 20 | 2011 | 94 | 0.630 |
Why?
|
| Animals | 29 | 2017 | 3293 | 0.610 |
Why?
|
| Lymphocyte Activation | 7 | 2013 | 76 | 0.560 |
Why?
|
| Mice, Knockout | 13 | 2013 | 281 | 0.560 |
Why?
|
| B-Lymphocytes | 4 | 2007 | 50 | 0.540 |
Why?
|
| Extracellular Matrix Proteins | 4 | 2005 | 38 | 0.470 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2013 | 94 | 0.400 |
Why?
|
| Th17 Cells | 1 | 2013 | 23 | 0.390 |
Why?
|
| Autoantibodies | 5 | 2007 | 63 | 0.380 |
Why?
|
| T-Lymphocyte Subsets | 5 | 2017 | 37 | 0.380 |
Why?
|
| Lymphocyte Depletion | 2 | 2011 | 3 | 0.370 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2011 | 3 | 0.360 |
Why?
|
| Lymphopenia | 1 | 2011 | 6 | 0.360 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 30 | 0.350 |
Why?
|
| Cytokines | 9 | 2015 | 202 | 0.340 |
Why?
|
| Antigen-Presenting Cells | 2 | 2013 | 8 | 0.330 |
Why?
|
| Immunity, Innate | 4 | 2007 | 55 | 0.330 |
Why?
|
| Arthritis | 3 | 2008 | 45 | 0.320 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 58 | 0.310 |
Why?
|
| Receptors, Cytokine | 1 | 2008 | 1 | 0.280 |
Why?
|
| Joints | 2 | 2008 | 66 | 0.280 |
Why?
|
| Signal Transduction | 4 | 2017 | 397 | 0.250 |
Why?
|
| Trans-Activators | 2 | 2003 | 21 | 0.240 |
Why?
|
| Female | 19 | 2013 | 12936 | 0.230 |
Why?
|
| Synovial Membrane | 3 | 2012 | 48 | 0.230 |
Why?
|
| Cells, Cultured | 7 | 2009 | 465 | 0.220 |
Why?
|
| Adjuvants, Immunologic | 2 | 2004 | 14 | 0.210 |
Why?
|
| T-Lymphocytes | 5 | 2015 | 94 | 0.210 |
Why?
|
| Disease Models, Animal | 9 | 2015 | 523 | 0.210 |
Why?
|
| Aggrecans | 5 | 2011 | 49 | 0.200 |
Why?
|
| Granulocytes | 3 | 2008 | 15 | 0.200 |
Why?
|
| Interleukin-2 | 1 | 2003 | 22 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2003 | 46 | 0.200 |
Why?
|
| Interleukin-10 | 1 | 2002 | 18 | 0.190 |
Why?
|
| Interleukin-12 | 1 | 2002 | 34 | 0.190 |
Why?
|
| Epitopes | 3 | 2015 | 39 | 0.190 |
Why?
|
| Apoptosis | 1 | 2003 | 194 | 0.190 |
Why?
|
| Severity of Illness Index | 5 | 2011 | 800 | 0.180 |
Why?
|
| Th2 Cells | 1 | 2001 | 15 | 0.180 |
Why?
|
| Antigen Presentation | 2 | 2015 | 14 | 0.180 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 228 | 0.170 |
Why?
|
| Lectins, C-Type | 4 | 2005 | 47 | 0.160 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2011 | 14 | 0.140 |
Why?
|
| Hyaluronan Receptors | 2 | 2008 | 5 | 0.140 |
Why?
|
| Interleukin-15 | 1 | 2017 | 8 | 0.140 |
Why?
|
| Mucous Membrane | 1 | 2017 | 24 | 0.130 |
Why?
|
| Humans | 17 | 2013 | 22914 | 0.130 |
Why?
|
| Immunologic Memory | 1 | 2017 | 23 | 0.130 |
Why?
|
| Spleen | 3 | 2008 | 28 | 0.130 |
Why?
|
| Mice, SCID | 6 | 2006 | 39 | 0.130 |
Why?
|
| Cell Differentiation | 2 | 2017 | 125 | 0.130 |
Why?
|
| CD4 Antigens | 2 | 2009 | 29 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 111 | 0.120 |
Why?
|
| Mice, Transgenic | 3 | 2009 | 173 | 0.120 |
Why?
|
| CD28 Antigens | 3 | 2004 | 5 | 0.120 |
Why?
|
| Immunotherapy, Active | 1 | 2015 | 2 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 5 | 2017 | 370 | 0.110 |
Why?
|
| Cartilage, Articular | 2 | 2011 | 253 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2004 | 46 | 0.100 |
Why?
|
| Antigens | 1 | 2013 | 9 | 0.100 |
Why?
|
| Quantitative Trait Loci | 2 | 2003 | 26 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 2013 | 34 | 0.100 |
Why?
|
| STAT6 Transcription Factor | 2 | 2003 | 10 | 0.100 |
Why?
|
| Autoimmune Diseases | 2 | 2003 | 26 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2013 | 71 | 0.100 |
Why?
|
| Cell Proliferation | 4 | 2006 | 161 | 0.100 |
Why?
|
| Inflammation | 2 | 2011 | 231 | 0.090 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2012 | 7 | 0.090 |
Why?
|
| Carrier Proteins | 2 | 2003 | 88 | 0.090 |
Why?
|
| Immunoglobulin Isotypes | 2 | 2002 | 3 | 0.090 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 25 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 32 | 0.090 |
Why?
|
| Interleukins | 2 | 2011 | 21 | 0.090 |
Why?
|
| Synovial Fluid | 1 | 2012 | 82 | 0.090 |
Why?
|
| Immunoglobulin G | 2 | 2002 | 67 | 0.090 |
Why?
|
| Mice, Inbred DBA | 4 | 2006 | 16 | 0.090 |
Why?
|
| Disease Susceptibility | 2 | 2009 | 56 | 0.090 |
Why?
|
| Interleukin-1beta | 2 | 2008 | 36 | 0.080 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2009 | 7 | 0.080 |
Why?
|
| Herpesvirus 2, Human | 1 | 2009 | 1 | 0.080 |
Why?
|
| Herpes Genitalis | 1 | 2009 | 2 | 0.080 |
Why?
|
| Receptors, CCR5 | 1 | 2009 | 13 | 0.080 |
Why?
|
| Gene Expression | 2 | 2009 | 176 | 0.080 |
Why?
|
| DNA, Viral | 1 | 2009 | 39 | 0.080 |
Why?
|
| Vagina | 1 | 2009 | 31 | 0.080 |
Why?
|
| Penetrance | 1 | 2009 | 2 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2009 | 260 | 0.070 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2009 | 20 | 0.070 |
Why?
|
| Leukocyte Rolling | 1 | 2008 | 1 | 0.070 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2008 | 11 | 0.070 |
Why?
|
| Receptors, Chemokine | 1 | 2008 | 9 | 0.070 |
Why?
|
| Osteoarthritis, Knee | 1 | 2012 | 298 | 0.070 |
Why?
|
| Osteoprotegerin | 1 | 2008 | 3 | 0.070 |
Why?
|
| RANK Ligand | 1 | 2008 | 2 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2008 | 50 | 0.070 |
Why?
|
| Peptidoglycan | 1 | 2008 | 1 | 0.070 |
Why?
|
| Receptors, Interleukin | 1 | 2008 | 3 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 19 | 0.070 |
Why?
|
| Autoantigens | 2 | 2005 | 15 | 0.070 |
Why?
|
| Bone Resorption | 1 | 2008 | 75 | 0.070 |
Why?
|
| Cartilage | 2 | 2005 | 67 | 0.070 |
Why?
|
| Antibodies | 1 | 2008 | 43 | 0.070 |
Why?
|
| HIV-1 | 1 | 2009 | 203 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 164 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2004 | 26 | 0.070 |
Why?
|
| Immunization | 2 | 2011 | 13 | 0.070 |
Why?
|
| Mice, Inbred C3H | 1 | 2007 | 18 | 0.070 |
Why?
|
| Phospholipases A | 1 | 2006 | 4 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 33 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2007 | 11 | 0.060 |
Why?
|
| Drug Synergism | 2 | 2004 | 38 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2007 | 70 | 0.060 |
Why?
|
| Protein Kinase C | 1 | 2006 | 47 | 0.060 |
Why?
|
| L-Selectin | 1 | 2006 | 7 | 0.060 |
Why?
|
| NADPH Oxidases | 1 | 2006 | 44 | 0.060 |
Why?
|
| Eosinophils | 1 | 2006 | 36 | 0.060 |
Why?
|
| Lymphocytes | 1 | 2006 | 51 | 0.060 |
Why?
|
| Adoptive Transfer | 2 | 2006 | 30 | 0.060 |
Why?
|
| Synovitis | 1 | 2006 | 19 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2008 | 165 | 0.060 |
Why?
|
| Hindlimb | 2 | 2003 | 15 | 0.060 |
Why?
|
| Protons | 1 | 2006 | 84 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 232 | 0.060 |
Why?
|
| Genes, Immunoglobulin | 1 | 2005 | 1 | 0.060 |
Why?
|
| Lymphocyte Cooperation | 1 | 2005 | 1 | 0.060 |
Why?
|
| Immunoglobulin M | 1 | 2005 | 11 | 0.060 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 10 | 0.060 |
Why?
|
| Ion Channels | 1 | 2006 | 204 | 0.060 |
Why?
|
| Disease Progression | 2 | 2006 | 522 | 0.060 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2003 | 1 | 0.050 |
Why?
|
| fas Receptor | 1 | 2003 | 5 | 0.050 |
Why?
|
| Fas Ligand Protein | 1 | 2003 | 6 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 18 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2003 | 16 | 0.050 |
Why?
|
| Ligands | 1 | 2003 | 37 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2003 | 7 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 50 | 0.050 |
Why?
|
| STAT4 Transcription Factor | 1 | 2002 | 1 | 0.050 |
Why?
|
| CD11b Antigen | 1 | 2002 | 13 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2002 | 13 | 0.050 |
Why?
|
| Cell Division | 1 | 2002 | 79 | 0.050 |
Why?
|
| Ligases | 1 | 2002 | 7 | 0.050 |
Why?
|
| Cell Movement | 2 | 2017 | 75 | 0.050 |
Why?
|
| Chemokines | 1 | 2002 | 15 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2002 | 21 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2002 | 23 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2002 | 29 | 0.050 |
Why?
|
| Collagen | 1 | 2002 | 79 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2003 | 141 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2002 | 276 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 75 | 0.040 |
Why?
|
| Rats | 1 | 2001 | 627 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 54 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 3 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2017 | 4 | 0.030 |
Why?
|
| Cell Adhesion | 2 | 2008 | 30 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2017 | 6 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2017 | 13 | 0.030 |
Why?
|
| Sirolimus | 1 | 2017 | 20 | 0.030 |
Why?
|
| Leukocytes | 2 | 2008 | 30 | 0.030 |
Why?
|
| Vaccines | 1 | 2015 | 7 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2006 | 109 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 2 | 2004 | 11 | 0.030 |
Why?
|
| Lipopeptides | 1 | 2012 | 8 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 85 | 0.020 |
Why?
|
| Male | 4 | 2012 | 12439 | 0.020 |
Why?
|
| Rheumatoid Factor | 1 | 2011 | 5 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 229 | 0.020 |
Why?
|
| Transgenes | 1 | 2009 | 10 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2009 | 43 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2008 | 35 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 168 | 0.020 |
Why?
|
| Phenotype | 1 | 2009 | 260 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 314 | 0.020 |
Why?
|
| Okadaic Acid | 1 | 2006 | 5 | 0.020 |
Why?
|
| Arachidonic Acids | 1 | 2006 | 6 | 0.020 |
Why?
|
| Maleimides | 1 | 2006 | 6 | 0.020 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2006 | 4 | 0.020 |
Why?
|
| Carcinogens | 1 | 2006 | 8 | 0.020 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2006 | 12 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2006 | 30 | 0.020 |
Why?
|
| Indoles | 1 | 2006 | 32 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2006 | 110 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 113 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 35 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 146 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2005 | 56 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 184 | 0.010 |
Why?
|
| B7-1 Antigen | 1 | 2004 | 4 | 0.010 |
Why?
|
| Abatacept | 1 | 2004 | 6 | 0.010 |
Why?
|
| CTLA-4 Antigen | 1 | 2004 | 2 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2004 | 11 | 0.010 |
Why?
|
| Immunoconjugates | 1 | 2004 | 7 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2004 | 49 | 0.010 |
Why?
|
| Lod Score | 1 | 2003 | 11 | 0.010 |
Why?
|
| X Chromosome | 1 | 2003 | 8 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2003 | 4 | 0.010 |
Why?
|
| Genome | 1 | 2003 | 7 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 47 | 0.010 |
Why?
|
| Collagen Type II | 1 | 2003 | 18 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2003 | 30 | 0.010 |
Why?
|
| Species Specificity | 1 | 2003 | 34 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2002 | 8 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 2002 | 7 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 163 | 0.010 |
Why?
|
| Isoantigens | 1 | 2002 | 2 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2002 | 20 | 0.010 |
Why?
|
| Sex Factors | 1 | 2003 | 384 | 0.010 |
Why?
|
| Biomarkers | 1 | 2003 | 477 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 7429 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 7896 | 0.010 |
Why?
|